#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	5074	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2348	628.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1580	1580	C	739	C,A,T	658,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7914	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4152	571.3	0	.	n	.	0	T695C	SNP	695	695	T	1309	1309	C	607	C,A	533,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7914	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4152	571.3	0	.	n	.	0	G856C	SNP	856	856	G	1470	1470	C	659	C	588	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7914	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4152	571.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1951	1951	A	681	A	613	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7914	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4152	571.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2585	2585	C	718	C,T	641,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7914	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4152	571.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3211	3211	T	682	T,G	612,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7914	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4152	571.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2659	2659	A	766	A,T	678,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	R7Q	NONSYN	19	21	CGG	528	530	CAG	96;95;95	C,T;A;G	86,1;84;86	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	543	545	AAA	100;100;100	A;A,C;A	89;87,2;90	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	600	602	TTG	102;102;103	T,G;T,C;G	95,1;94,1;96	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	S68P	NONSYN	202	204	TCG	711	713	CCG	117;118;116	C,T,A;C;G	103,1,1;106;106	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	F72Y	NONSYN	214	216	TTC	723	725	TAT	115;114;115	T;A,T,C;T,C	107;103,1,1;104,1	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	P74S	NONSYN	220	222	CCG	729	731	TCG	116;115;115	T,C;C;G,T	103,1;102;100,1	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	A89V	NONSYN	265	267	GCG	774	776	GTG	112;111;111	G;T,C;G	102;97,1;102	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	960	962	AAA	124;123;123	A,G;A;A	109,1;109;110	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	566	folP	852	852	98.24	folP.l15.c4.ctg.1	2056	82.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1191	1193	AGC	138;137;137	A;G;C	121;125;120	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1548	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4060	114.3	1	SNP	p	S91F	0	.	.	271	273	TCC	919	921	TCC	142;142;143	T;C;CG,C	127;125;126,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1548	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4060	114.3	1	SNP	p	D95G	0	.	.	283	285	GAC	931	933	GAC	140;139;139	G;A,C;C	132;127,1;126	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1548	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4060	114.3	1	SNP	p	D95N	0	.	.	283	285	GAC	931	933	GAC	140;139;139	G;A,C;C	132;127,1;126	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	672	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1898	106.3	1	SNP	p	G45D	1	.	.	133	135	GAC	797	799	GAC	160;160;160	G;A,C;C	143;137,1;145	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	456	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1664	82.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1582	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3287	143.6	1	SNP	p	D86N	0	.	.	256	258	GAC	707	709	GAC	190;190;190	G,C;A,C;C	168,1;163,1;168	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1582	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3287	143.6	1	SNP	p	S88P	0	.	.	262	264	TCC	713	715	TCC	186;186;186	T;C;C	162;160;164	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1352	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3225	125.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1818	1820	GGC	174;172;171	G;G,A;C	159;154,1;150	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1443	1445	GCA	175;176;175	G;C;A	156;154;163	penA.15.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1446	1448	ATC	176;176;176	A;T,C;C,A	153;155,1;158,1	penA.15.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1458	1460	GTG	176;176;176	G;T;G	157;152;158	penA.15.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1458	1460	GTG	176;176;176	G;T;G	157;152;158	penA.15.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1959	1961	ACC	131;131;131	A,C;C;C	117,1;115;120	penA.15.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2013	2015	GCG	131;132;132	G;C,T;G,T	116;101,1;106,1	penA.15.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2013	2015	GCG	131;132;132	G;C,T;G,T	116;101,1;106,1	penA.15.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	G542S	0	.	.	1624	1626	GGC	2136	2138	GGC	131;132;132	G,C;G;C	111,1;117;118	penA.15.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2145	2147	GGC	133;133;133	G;G;C	115;117;117	penA.15.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1148	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2800	122.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2163	2165	CCG	132;132;133	C;C,G;G	110;115,1;111	penA.15.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1578	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3747	126.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2003	2005	CCG	137;137;138	C,G;C;G	124,1;123;122	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	794	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2319	102.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	674	676	GGC	145;145;144	G,A,T;G;C	120,1,1;126;129	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	794	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2319	102.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	856	856	C	141	C,T	122,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1141	1143	AAT	19;19;19	A;A;T	18;18;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1144	1146	AAT	18;18;18	A;A;T	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1168	1170	GCA	18;18;18	G;C;A	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1191	1193	GCA	18;18;18	G;C;A	16;17;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1197	1199	AAC	18;18;18	A;A;C	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1201	1206	TGGCAT	18;18;18;18;18;18	T;G;G;C;A;T	17;16;17;17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1207	1209	GCT	18;18;18	G;C;T	16;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1267	1269	TTA	16;16;16	T;T;A	13;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1312	1314	CAT	18;18;18	C;A;T	14;14;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1315	1317	AGT	18;18;18	A;G;T	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	134	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1404	26.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1324	1326	TAC	18;18;18	T;A;C	15;15;15	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	954	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	2298	124.3	0	.	p	.	0	.	INDELS	629	630	AA	1288	1290	TAG	170;170;170	T;A;G	148;150;151	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	954	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	2298	124.3	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1292	1295	CAAT	166;166;164;164	C;A;A;T	153;153;147;147	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	954	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	2298	124.3	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1297	1297	T	165	T	145	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	954	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	2298	124.3	1	SNP	p	G120K	0	.	.	358	360	GGT	1016	1018	GGT	201;201;202	G;G,T;T	188;176,1;179	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	954	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	2298	124.3	1	SNP	p	A121D	0	.	.	361	363	GCC	1019	1021	GCC	200;199;200	G,A;C;C	174,1;176;183	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	954	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	2298	124.3	1	SNP	p	A121N	0	.	.	361	363	GCC	1019	1021	GCC	200;199;200	G,A;C;C	174,1;176;183	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3004	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5279	170.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	508	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1470	103.3	1	SNP	p	V57M	1	.	.	169	171	ATG	774	776	ATG	179;178;178	A;T;G	164;163;164	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
